93.57MMarket Cap
LossP/E TTM
HRTX Balance Sheet
You can check out the annual or quarterly balance sheets of Heron Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing HRTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Heron Therapeutics Inc Have?
In its most recent quarterly, Heron Therapeutics Inc had 26.12M in cash and cash equivalents.
How Much Are Heron Therapeutics Inc's Total Liabilities?
Heron Therapeutics Inc reported 241.54M in total liabilities as of the latest reported quarter, including 96.10M in current liabilities and 145.45M in non-current liabilities.
What Are Heron Therapeutics Inc's Total Assets?
As of the latest reported quarter, Heron Therapeutics Inc's total assets were 255.88M, consisting of 238.07M in current assets and 17.81M in non-current assets.
How Much Shareholders' Equity Does Heron Therapeutics Inc Have?
Heron Therapeutics Inc reported 14.33M in total shareholders' equity as of the latest reported quarter.